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Abstract
Objective—Rheumatoid arthritis (RA) is classically thought of as a Th1, T lymphocyte–driven
disease of the adaptive immune system. However, cells of the innate immune system, including
neutrophils, are prevalent within the diseased joint, and accumulate in large numbers. This study
was undertaken to determine whether cells of the rheumatoid stromal microenvironment could
establish an inflammatory environment in which endothelial cells are conditioned in a disease-
specific manner to support neutrophil recruitment.
Methods—Human umbilical vein endothelial cells (ECs) and fibroblasts isolated from the
synovium or skin of RA patients were established in coculture on opposite sides of porous
transwell filters. After 24 hours of EC conditioning, the membranes were incorporated into a
parallel-plate, flow-based adhesion assay and levels of neutrophil adhesion to ECs were measured.
Results—ECs cocultured with synovial, but not skin, fibroblasts could recruit neutrophils in a
manner that was dependent on the number of fibroblasts. Antibody blockade of P-selectin or E-
selectin reduced neutrophil adhesion, and an antibody against CD18 (the β2 integrin) abolished
adhesion. Blockade of CXCR2, but not CXCR1, also greatly inhibited neutrophil recruitment.
Interleukin-6 (IL-6) was detectable in coculture supernatants, and both IL-6 and neutrophil
adhesion were reduced in a dose-dependent manner by hydrocortisone added to cocultures.
Antibody blockade of IL-6 also effectively abolished neutrophil adhesion.
Conclusion—Synovial fibroblasts from the rheumatoid joint play an important role in regulating
the recruitment of inflammatory leukocytes during active disease. This process may depend on a
previously unsuspected route of IL-6–mediated crosstalk between fibroblasts and endothelial cells.
The recruitment of blood-borne leukocytes by endothelial cells (ECs) lining the blood
vessels, typically postcapillary venules, is an early step in the inflammatory response (1). It
is a process that is down-regulated in acute or resolving inflammation, but appears to
continue in a disease-regulated manner in chronic inflammatory diseases (2). For example,
in rheumatoid arthritis (RA), lymphocytes (B and T), monocytes, and neutrophils are
recruited over protracted periods into the diseased joint. This dysregulation of the
inflammatory response is probably related to the imposition of a disease-specific,
continuously activated phenotype on the ECs of the joint vasculature (3). The mechanisms
that regulate long-term EC activation and leukocyte accumulation in diseased tissue are
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poorly understood, but it is probable that part of the process is supported by cytokines and
chemokines released by stromal cells of the affected tissue.
A number of studies have demonstrated the ability of stromal cells to alter the local
microenvironment in a manner that contributes to disease. For example, in a model of
atherosclerosis, smooth muscle cells could sensitize cocultured ECs in a manner dependent
on transforming growth factor β1 so that the adhesion of neutrophils greatly increased in
response to EC activation by tumor necrosis factor α (TNFα) (4,5). Fibroblasts and corneal
stromal cells (keratocytes) alter the local microenvironment by inhibiting the release of the
antiinflammatory cytokines interleukin-4 (IL-4) and IL-10 from activated T cells in a
mechanism that enhances protective immune reactions in the anterior segment of the eye (6).
Of particular relevance, there is growing evidence that synovial fibroblasts contribute to
inflammatory processes that underpin RA and assist in the destruction of bone and cartilage
by, for example, changing phenotypes so that they generate inflammatory cytokines and
matrix metalloproteinases (7-14). An important alteration in the rheumatoid
microenvironment is the high level of expression of IL-6 (15), IL-1, and TNFα (16).
However, the source of these agents in the complex cellular environment of the arthritic
joint remains unknown.
In clinical practice, various treatments target the production of proinflammatory cytokines.
Such therapies include systemic administration of hydrocortisone or its analogs, which have
been commonly used for more than 50 years. However, while short-term relief of symptoms
is apparent, the long-term effects of this treatment are detrimental and the mechanism(s) of
action are unclear. They may include down-regulation of proinflammatory cytokines and
promotion of the synthesis of antiinflammatory cytokines and the inhibition of leukocyte
adhesion (17-20). Other treatments directly target proinflammatory cytokines. Thus, anti-
TNFα therapy has shown good efficacy in the reduction of symptoms associated with active
rheumatoid disease, and some studies suggest that blocking the function of IL-1 protects
bone and cartilage (21). However, it is still unclear whether reducing the bioactivity of these
cytokines reduces EC activation and thereby the recruitment of inflammatory leukocytes.
Additionally, 30% of patients treated with anti-TNFα do not respond to treatment (22),
strongly implying that there are other mechanisms that promote chronic inflammation within
the rheumatoid environment.
Because the spatial and temporal complexity of the rheumatoid environment makes it
extremely difficult to examine the detail of the inflammatory processes that occur in vivo,
we developed an in vitro coculture system that reconstitutes aspects of the rheumatoid
stromal microenvironment and allows us to investigate the regulation of inflammation in this
environment. This allowed us to test the hypothesis that synovial fibroblasts are imprinted
with a proinflammatory phenotype that can promote the recruitment of leukocytes by
activating cocultured ECs. Here we show that a previously unsuspected process of crosstalk
involving IL-6 signaling occurs between synovial fibroblasts and vascular ECs, which
results in up-regulation of adhesion molecules and chemokines that support neutrophil
recruitment.
MATERIALS AND METHODS
Neutrophil preparation
Blood from healthy adult volunteers was collected and placed into EDTA (1.6 mg/ml) in
accordance with local ethical guidelines and with the approval of the South Birmingham
Local Research Ethics Committee. Neutrophils were separated using 2-step density
gradients of Histopaque 1119 and 1077 (all reagents were obtained from Sigma, Poole, UK,
unless otherwise stated), as previously described (1,2). Neutrophils were >95% pure based
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on volume distribution, which was determined using a Coulter Multisizer II (Beckman
Coulter, Fullerton, CA).
Isolation and culture of fibroblasts and ECs
Matched synovium and skin tissue was obtained during total knee arthroplasty from
consenting patients who fulfilled the American College of Rheumatology (formerly, the
American Rheumatism Association) criteria for RA (23). Fibroblasts were isolated by
morselization of tissues, followed by dissociation in 5mM EDTA for 2 hours. Dissociated
tissue was washed and transferred to culture flasks in RPMI 1640 medium supplemented
with 20% fetal calf serum (FCS), 1% nonessential amino acids, 1% (100 mM) sodium
pyruvate, 2 mM glutamine, 100 units/ml penicillin, and 100 μg/ml streptomycin. Once cells
had attached, excess cells and tissue were removed. Medium was changed every 4 days until
near-confluence, at which point cells were subcultured. Fibroblast phenotypes were
confirmed by positive staining for prolyl-4-hydroxylase and fibronectin (Figure 1), and
negative staining for contaminating cell populations using CD14, CD68, CD31, von
Willebrand factor, and cytokeratin. Fibroblasts thus obtained from patient tissue biopsy
samples were used between passages 3 and 10 for coculture experiments.
Human umbilical vein ECs were enzymatically isolated and cultured in medium (Medium
199; Invitrogen, Paisley, UK) containing 28 μg/ml gentamicin, 20% FCS, 1 μg/ml
hydrocortisone, and 10 ng/ml epidermal growth factor, as previously described (24). ECs
were grown to confluence in 25-cm2 culture flasks (BD Falcon, Oxford, UK) precoated with
1% gelatin solution (Sigma).
Preparation of coculture inserts
ECs and fibroblasts were cocultured on opposite sides of porous polyethylene terepthalate
inserts (Becton Dickinson, Franklin Lakes, NJ) (Figure 2A). The membranes on the inserts
had an effective culture area of 0.3 cm2, a pore size of 0.4 μm, and a pore density of 1 × 108/
cm2. Both fibroblasts and ECs were dispersed in 0.02% EDTA–2.5 mg/ml−1 trypsin. The
cells were washed with RPMI 1640 and centrifuged for 5 minutes at 400g followed by
resuspension in fibroblast culture medium. After being counted with a hemocytometer,
between 104 and 105 fibroblasts were added to the inside of the inserts and cultured for 24
hours. ECs were added to the opposite side of the inserts containing fibroblasts, or to empty
inserts as controls, as previously described (4,5), and at a concentration that allowed a
confluent monolayer after the cells were attached to and spread on the membrane. ECs were
conditioned by coculture for 24 hours prior to flow-based adhesion assay. In some
experiments, reagents that inhibited EC-activating agents were incorporated at the initiation
of coculture.
Parallel-plate flow-based adhesion assay
Flow-based adhesion experiments were conducted in a parallel-plate assay adapted from one
that was previously described (4,5). The system was composed of an upper Perspex plate
(Figure 2B) that contained a recess to accept a glass coverslip which formed the upper wall
of the flow channel, and through which microscopic observations were made. The lower
plate, which formed the bottom of the flow channel, was separated from the upper plate by a
noncompressible silicone gasket that defined the depth of the flow channel (150 μm). Inlet
and outlet conduits allowed the flow of medium that contained neutrophils. The lower plate
was engineered so that inserts with cocultures could be incorporated into the flow channel.
When the insert was in situ, the EC monolayer formed the bottom of the flow channel,
where the insert protruded through the lower plate. The parallel plates and gasket were
sealed with hand-tightened screws so that medium could pass through the flow channel
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unhindered. The insert was held firmly in the lower plate by a small sealing plate and gasket,
which were held in place with 4 locating screws.
The parallel-plate apparatus was placed on the stage of an upright fluorescence microscope
(BX61 using an LCPlanFL 20× objective lens, numerical aperture of 0.4; Olympus,
Melville, NY), and silicone tubing connected the inlet conduit to a microelectronic
switching valve that regulated the choice between neutrophil suspension and wash buffer.
The outlet conduit was connected to a Harvard syringe pump that drew medium through the
plate and across the ECs at a wall shear stress of 0.1 Pa. The system was maintained at 37°C
using a thermostatically controlled Perspex surround, which enclosed the microscope stage,
sample holder, and parallel-plate system. Prior to measurement, neutrophils suspended in
phosphate buffered saline containing 0.1% bovine serum albumin were fluorescently labeled
for 15 minutes with 1 μg/ml of the dye bisbenzimide. Neutrophils were perfused at a
concentration of 106/ml for 3 minutes, followed by addition of cell-free buffer to remove
nonadherent cells. After 2 minutes of wash buffer perfusion, video records were made of 10
microscopic fields of view selected at random along the centerline of the insert. Video
records were digitized using analysis software (Image Pro Plus; Media Cybernetics, Silver
Spring, MD), adherent cells were counted, and data were expressed as cell number/mm2/106
perfused.
Measurement of soluble IL-6
Soluble IL-6 in supernatants from cultured or cocultured cells was measured using a
commercially available sandwich enzyme-linked immunosorbent assay according to the
manufacturer’s instructions (R&D Systems, Abingdon, UK). Data were expressed in pg/ml
as determined using a calibration curve constructed using recombinant IL-6.
Cell treatments
In some experiments, we included hydrocortisone (2.5 × 10−9−2.5 × 10−3M) or neutralizing
antibodies against IL-6 (50 μg/ml−1; IgG1) (clone 6708; R&D Systems), TNFα (50 μg/
ml−1; IgG1) (clone 1825.12; R&D Systems), or IL-1β (50 μg/ml−1; IgG1) (clone 8516.311;
R&D Systems) when cocultures were established. In experiments to identify the molecules
that directly supported neutrophil adhesion and activation, we treated cocultured ECs with
rabbit polyclonal antibodies against P-selectin (a gift of Michael Berndt, Baker Medical
Research Institute, Melbourne, Australia), E-selectin (1 μg/ml, F[ab’]2 of clone ENA2;
Bradshaw Biologicals, Chepshet, UK), or a nonimmune control antibody (25 μg/ml−1, rabbit
polyclonal antibody; Dako, High Wycombe, UK) prior to neutrophil perfusion.
Alternatively, neutrophils were treated with antibodies against CD18 (β2 integrin) (10 μg/
ml−1; IgG1) (clone R6.5E; Genentech, South San Francisco, CA) or CXCR1 or CXCR2
(both 2 μg/ml−1; IgG1) (clones 501 and 19, respectively; BioSource International,
Camarillo, CA) prior to perfusion. In some experiments, function-neutralizing antibodies
against CXC chemokines (all IgG1 and all used at 10 μg/ml) (clone 33160.111 against
epithelial neutrophil–activating peptide 78 [ENA-78], clone 31716.11 against growth-related
oncogene α [GROα], clone 6217.111 against IL-8; R&D Systems) were used prior to
adhesion assay.
Statistical analysis
Statistical comparisons of individual treatments were performed using Student’s paired 2-
tailed t-test. Effects of hydrocortisone dosage were tested using analysis of covariance
followed by Student’s paired t-test, where appropriate. Correlations between IL-6 levels in
coculture medium and the levels of neutrophil adhesion supported by cocultured ECs were
calculated using Pearson’s correlation test assuming a Gaussian distribution. P values less
than or equal to 0.05 (2-sided) were considered significant.
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RESULTS
Adhesion of flowing neutrophils supported by ECs cocultured with synovial fibroblasts
When ECs were cultured for 24 hours with fibroblasts from the rheumatoid synovium and
then incorporated into the parallel-plate flow adhesion assay, the ECs were able to support
the adhesion of flowing neutrophils (Figure 3). Importantly, the levels of neutrophil
adhesion to ECs cocultured with skin fibroblasts explanted from the same patients were
negligible (Figure 3). The levels of adhesion supported by ECs cocultured with different
rheumatoid fibroblast explants varied (Figure 3A), although neutrophils were recruited by
ECs cocultured with all the synovial fibroblast explants tested (Figures 3A and B). We also
examined the effects of varying the number of fibroblasts in coculture with ECs. Fibroblasts
at concentrations between 1 × 104/insert and 1 × 105/insert induced a graded increase of
neutrophil recruitment to cocultured ECs (Figure 3C). Importantly, skin fibroblasts did not
show an ability to support neutrophil adhesion at any density of seeding.
Necessity of selectin and β2 integrin receptors and CXC chemokine ENA-78 for neutrophil
adhesion
To identify the receptors involved in the initial capture and adhesion of neutrophils,
antibodies against endothelial and neutrophil receptors were used at the time of flow assay.
The blockade of E-selectin or P-selectin on ECs reduced the levels of neutrophil adhesion to
synovial fibroblast/EC cocultures, with the P-selectin blockade more efficient than the
blockade of E-selectin (Figure 4A). The effect of combining both antibodies resulted in a
further decrease in adhesion, indicating that both E-selectin and P-selectin contributed to the
adhesion of neutrophils from flow. Interestingly, the inclusion of a β2 integrin–blocking
antibody completely inhibited stable neutrophil adhesion (Figure 4A), which suggests that in
the absence of integrin-mediated interactions, neutrophil interactions with the EC monolayer
via selectin receptors were transient, and prolonged rolling adhesion was not established.
The integrin-mediated adhesion of neutrophils to ECs typically requires activation of the
neutrophils. We have previously reported that in a flow-based model using TNFα-activated
ECs, activation through the neutrophil chemokine receptor CXCR2 was required for β2
integrin-mediated adhesion (25). Here, the use of an anti-CXCR2 antibody completely
inhibited neutrophil adhesion to ECs cocultured with synovial fibroblasts, while an anti-
CXCR1 antibody had no consistent effect on neutrophil behavior (Figure 4B). When
function-neutralizing antibodies against CXC chemokines were incorporated into the
coculture system, neutrophil adhesion was effectively inhibited by an anti–ENA-78 antibody
but not by anti-GROα or anti–IL-8 antibodies (Figure 4C), which strongly indicates that a
single chemokine (ENA-78), which operated through CXCR2, was responsible for the
activation of neutrophils in this system.
Inhibition of EC responses to synovial fibroblasts by hydrocortisone or inhibition of IL-6
activity
The addition of hydrocortisone to the coculture medium over a broad range of
concentrations inhibited neutrophil adhesion to ECs cocultured with synovial fibroblasts in a
dose-dependent manner (Figure 5A). Because hydrocortisone has been reported to reduce
the expression of IL-6 by fibroblasts (26), we measured the concentration of this cytokine in
our coculture medium in the presence of different concentrations of hydrocortisone.
Hydrocortisone reduced the levels of IL-6 detectable in the coculture medium in a dose-
dependent manner (Figure 5B). Furthermore, there was a significant correlation between the
levels of IL-6 in the coculture medium and the levels of neutrophil adhesion to ECs
cocultured with synovial fibroblasts (Figure 5C), indicating that IL-6 activity in the
coculture system might be important in the process of EC activation. To test this hypothesis,
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at the initiation of coculture we added a function-neutralizing anti–IL-6 antibody. This
completely inhibited neutrophil adhesion to the ECs cocultured with synovial fibroblasts
(Figure 6). Interestingly, isotype-matched, function-neutralizing antibodies against TNFα or
IL-1β had no consistent effect on neutrophil adhesion in the coculture system.
DISCUSSION
The concept that inflammation is regulated by cells of the tissue stroma is well established,
although the key regulatory components are usually considered to be highly specialized
cells, such as tissue macrophages and mast cells, that have differentiated from leukocytic
precursors. Recently it has become clear that cells such as fibroblasts, which were thought to
be relatively inert structural components of the tissue, actually play important roles in
regulating tissue homeostasis in health and disease. These cells may play a particularly
important role in chronic inflammatory diseases (including RA), in which they undergo a
disease-specific transition in phenotype, often show hyperplastic responses to the disease
environment (leading to degradation of the normal tissue architecture), and help perpetuate
disease-associated pathology by promoting inflammation (7-15).
In the current study, we investigated the ability of fibroblasts derived from different tissue
sites to regulate the recruitment of flowing neutrophils to cocultured ECs. We tested the
hypothesis that fibroblasts derived from the rheumatic joint would have a proinflammatory
phenotype conferred on them by residence in chronically inflamed tissue. Using a unique
multicellular model of the synovial microenvironment, we identified a previously
undescribed interaction between rheumatoid fibroblasts and ECs that promotes the
recruitment of flowing neutrophils. The process of cellular crosstalk that supported EC
activation depended on IL-6 signaling. Importantly, the ability to promote neutrophil
recruitment was restricted to fibroblasts derived from the rheumatoid environment, because
fibroblasts from the skin of the same patients were unable to activate ECs.
The adhesion receptors that support the prolonged recruitment of neutrophils into the
rheumatoid synovium in vivo remain to be definitively described. However, during active
disease, elevated levels of soluble E-selectin and intercellular adhesion molecule 1
(ICAM-1) in the serum have been reported, with the implication that these receptors are
shed from the inflamed vasculature of the rheumatoid pannus (27). Paeolog and collegues
reported that treatment of patients with anti-TNFα antibody (cA2) reduced the circulating
levels of these receptors in a manner that correlated with clinical benefit (28). They
proposed that the observed decrease reflected diminished activation of ECs in the synovial
microvasculature, which might lead to reduced migration of leukocytes (28). The expression
of ICAM-1, E-selectin, and P-selectin has also been demonstrated immunohistochemically
in human synovial tissues (29,30). Additionally, in a number of rodent models of resolving
arthritis, the use of antibodies targeting E-selectin or P-selectin reduced leukocyte (including
neutrophil) recruitment into affected joints (31-33). Taken together, these observations
strongly implicate both E-selectin and P-selectin in the recruitment of neutrophils in RA and
might also indicate that TNFα plays an important role in the activation of the synovial
microvasculature in RA.
In our in vitro model of the RA synovium, we identified roles for both E-selectin and P-
selectin in neutrophil recruitment. Interestingly, however, we were able to exclude a role for
TNFα in the process of crosstalk between RA fibroblasts and ECs. The identification of a
novel route of cellular crosstalk that results in EC activation independent of TNFα signaling
has implications for targeted treatment of RA. Approximately 30% of patients do not
respond to treatment with anti-TNFα antibodies and it is tempting to speculate that in these
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individuals, alternative routes of EC activation, such as that demonstrated here, may support
the prolonged recruitment of inflammatory leukocytes.
In the current study, we identified a critical role for IL-6 in the regulation of neutrophil
adhesion to cocultured ECs. IL-6 was first identified and cloned as the 26-kd B cell
differentiation factor (34). However, more recent evidence shows that IL-6 is a pleiotropic
agent, which plays an important role in hematopoiesis, the acute-phase response, and in
many inflammatory diseases, including RA (35). In RA, IL-6 is required to activate
autoreactive T cells, induce the production of rheumatoid factor and other autoreactive
antibodies, and promote the acute-phase response (35). In murine models of antigen-induced
monarthritis (36), collagen-induced arthritis (37), and spontaneous T cell–mediated chronic
autoimmune arthritis (38), knockout of the IL-6 gene significantly reduced joint swelling,
synovial infiltration of leukocytes, and bone and cartilage erosion. These effects were
reversible in some models upon the infusion of a soluble IL-6 receptor (sIL-6R)/IL-6 fusion
protein (36). Moreover, clinical trials in RA patients using humanized anti–IL-6R antibody
showed a dose-related reduction in inflammation (39,40).
Thus, IL-6 appears to play a critical role in the processes that typify human and animal
arthritic disease. Cognate IL-6 receptors are restricted to hepatocytes, megakaryocytes,
leukocytes, and fibroblasts, but have not been reported on ECs (26). However, there is also
an sIL-6R, which is proteolytically shed by various leukocyte subsets upon activation
(41-44), as well as an alternatively spliced product of the IL-6R gene reported to be secreted
exclusively in the inflamed synovium of RA patients. Trans-signaling by sIL-6R requires the
formation of a heterodimeric complex of IL-6/sIL-6R and the nonligand binding signal
transducer gp130 (45). Signaling via this complex has been shown to promote EC
expression of E-selectin, IL-8, ICAM-1, and vascular cellular adhesion molecule 1
(VCAM-1) (37).
In our model of the RA synovium, we did not detect sIL-6R when we screened coculture
supernatants (data not shown). Thus, although IL-6 was essential for promoting neutrophil
adhesion in our coculture system, it is probable that it did not directly activate ECs. Rather,
we propose that IL-6 stimulates fibroblasts, which are known to express IL-6R (46) and
which, in the presence of accessory signals derived from the coculture environment,
generate an EC-activating agent(s) that is responsible for promoting neutrophil recruitment.
Interestingly, we could find no role for TNFα or IL-1β in our system, nor were these agents
released into coculture supernatants (data not shown), indicating that the agent(s)
responsible for EC activation may be one that is not commonly associated with
inflammation in RA.
Hydrocortisone is a potent antiinflammatory steroid that has been used in the treatment of
RA for the past 50 years. However, there is still much debate about the mechanisms of this
agent in RA. The inhibitory actions of glucocorticoid steroids on the leukocyte adhesion
cascade have been previously described. For example, Cronstein et al (47) showed that
dexamethasone caused a dose-dependent decrease in neutrophil adhesion to
lipopolysaccharide-stimulated ECs in a static assay, and that this was due to a decrease in
both E-selectin and ICAM-1 messenger RNA (mRNA) and protein. Dexamethasone also
reduced E-selectin mRNA expression in IL-1β- but not TNFα-stimulated ECs in their
system (47), although the TNFα- or IL-1β–induced surface expression of E-selectin and
VCAM-1 was decreased in another series of experiments (48).
Our own flow-based studies on the regulation of neutrophil adhesion to TNFα-stimulated
ECs show that hydrocortisone is ineffective on ECs stimulated with high concentrations of
TNFα (100 units/ml) but efficiently inhibits neutrophil adhesion at lower TNFα
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concentrations (1 unit/ml) (Nash GB, Rainger GE: unpublished observations). Additionally,
neutrophil recruitment into inflamed human conjunctiva and P-selectin expression in this
tissue were decreased by hydrocortisone treatment (49). Thus, hydrocortisone can have
direct effects on ECs and the expression of molecules that support the adhesion of
leukocytes.
In the current study we found that the addition of hydrocortisone to the coculture medium
reduced neutrophil adhesion dose-dependently and in a manner that correlated closely with a
reduction in IL-6 release, an observation that is consistent with the reported ability of
synthetic glucocorticoids to inhibit IL-6 expression at the mRNA and protein levels in
synovial fibroblasts (26). This observation led us to directly test the hypothesis that
neutralizing IL-6 would inhibit the adhesion of neutrophils to cocultured ECs. Thus,
although hydrocortisone may directly affect EC expression of adhesion receptors that
support neutrophil adhesion, it is also likely that effects on the phenotype of cocultured
fibroblasts play an important role in moderating the inflammatory pathways operating in this
model.
In conclusion, an important advantage of using in vitro models that recapitulate aspects of
the stromal microenvironment is the ability to interfere directly in the crosstalk between
specific cell types, a difficult process in the complex cellular environment of the diseased
tissue. Using simple inhibitor strategies (e.g., the addition of a function-neutralizing anti–
IL-6 antibody), we have been able to demonstrate a previously unsuspected route of
fibroblast-EC interaction, which may support the ongoing process of leukocyte recruitment
into the rheumatoid microenvironment. Thus, our system may faithfully mimic important in
vivo processes involved in leukocyte accumulation within the synovium, and might provide
a useful screen for new antiinflammation therapies in RA.
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Figure 1.
Confirmation of fibroblast phenotype. Fibroblasts from 4 patients with rheumatoid arthritis
(RA) were isolated from synovium (RASY) or skin (RADF) obtained at total knee
arthroplasty. Cells were stained for the fibroblast marker fibronectin.
Lally et al. Page 12
Arthritis Rheum. Author manuscript; available in PMC 2011 June 21.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 2.
Assembly of coculture inserts. A, A porous polyethylene terepthalate culture insert on which
cocultures were established by growing fibroblast and endothelial cells (ECs) on opposite
sides of the porous membrane. B, The parallel-plate, flow-based adhesion assay assembled
with coculture in situ. C, The components of the assay included an upper Perspex plate (i)
that had a machined recess to accept a glass coverslip (ii), which formed the upper surface of
the flow channel. A silicone gasket (iii) defined the depth of the flow channel (150 μm). The
lower acetal plastic plate (iv) formed the lower surface of the flow channel and had a recess
into which the culture insert fit so that the ECs also formed part of the lower surface of the
flow channel. The insert (v) was held in place by a Perspex plate (vi) and a smaller silicone
gasket (vii). Inlet and outlet conduits (viii) allowed the flow of leukocyte suspension or wash
buffer through the flow channel. The plates were held together firmly by locating screws (ix
and x).
Lally et al. Page 13
Arthritis Rheum. Author manuscript; available in PMC 2011 June 21.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
Figure 3.
Adhesion of flowing neutrophils to endothelial cells (ECs) cocultured with fibroblasts. A, A
comparison of synovial (RASY) and skin (RADF) fibroblast explants from 5 different
patients with rheumatoid arthritis (RA). B, The mean ± SEM response of ECs cultured with
fibroblasts from the 5 donors. C, Effects of varying the number of fibroblasts in coculture
with ECs. Values are the mean ± SEM in the 5 donors.
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Figure 4.
Levels of neutrophil adhesion achieved with antibody blockade. A, Effects of anti–E-
selectin, anti–P-selectin, a combination of these antibodies, a control antibody, or blockade
of CD18 (β2 integrin). B, Neutrophil adhesion levels with the use of anti-CXCR1, anti-
CXCR2, or a combination of these antibodies. C, Effects of anti–epithelial neutrophil–
activating peptide 78 (ENA-78), growth-related oncogene α (GROα), or interleukin-8
(IL-8) (all CXC chemokines). Values are the mean and SEM from at least 4 experiments
using different endothelial cells and fibroblast explants. RASY = fibroblasts isolated from
synovium of rheumatoid arthritis patients. * = P < 0.05 versus untreated control, by
Student’s paired t-test.
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Figure 5.
Role of hydrocortisone and interleukin-6 (IL-6) activity in neutrophil adhesion. A and B,
Effects of hydrocortisone on A, the adhesion of neutrophils to ECs cocultured with RASY
and RADF, and B, the levels of IL-6 released into the medium by cocultured cells. Values
are the mean and SEM from at least 4 experiments using different ECs and fibroblast
explants. C, Correlation between levels of IL-6 released into coculture medium and levels of
neutrophil adhesion to ECs cocultured with fibroblasts. See Figure 3 for other definitions.
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Figure 6.
Effect of antibody blockade of the biologic function of interleukin-6 (IL-6), tumor necrosis
factor α (TNFα), or IL-1β on neutrophil adhesion. Values are the mean and SEM levels of
neutrophil adhesion. * = P < 0.05, by Pearson’s correlation test assuming a Gaussian
distribution.
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